Carey Stephen P.'s Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed Mar 11, 2024
- Accession no.
- 0001674236-24-000007
- Filed
- Mar 11, 2024
- Trade date
- Mar 7-11, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $510.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Carey Stephen P.CIK 0001674236 | Officer (SVP & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Stock | FTax withholdingDisposed | −4,216 | $66.71 | −$281,249.36 | 185,499 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −7,787 | $65.55F2 | −$510,437.85 | 177,712 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were sold in multiple trades at prices ranging from $65.08 to $66.63. The price reported above reflects the weighted average sales price.
Referenced by the price of 1 transaction in Table I.